文献速递甲状腺与颈部外科围术期管理与 ERAS

原发性甲状旁腺功能亢进症的终末器官损害

End-Organ Damage Associated With Primary Hyperparathyroidism.
PubMed 文献 · JAMA Surg · 2026-01-01

这项基于美国全国电子健康记录和理赔数据的队列研究纳入43 399例新发原发性甲状旁腺功能亢进症(PHPT)成人,发现51.3%在诊断时已有终末器官损害,未损害者中32.0%在中位516天后进展,但接受甲状旁腺切除术者比例低。

要点

  • PHPT诊断时超半数患者已存在终末器官损害
  • 无损害者随访中约三分之一进展,中位516天
  • 甲状旁腺切除术使用率低,仅约20%有损害者手术

核心结论

  • 在该全国成人PHPT队列中,67%在诊断时或随访期间出现PHPT相关终末器官损害。
  • 尽管终末器官损害常见,甲状旁腺切除术的使用并不普遍。

研究设计与样本

  • 基于2010-2023年全国电子健康记录和理赔数据的人群队列研究,随访至2023年。
  • 纳入新发生化诊断PHPT的成人,共43 399例,平均年龄67.9岁,78%为女性。

主要发现

  • 诊断时22 279例(51.3%)存在终末器官损害。
  • 诊断时无损害的21 120例中,6762例(32.0%)在中位516天后进展为终末器官损害。
  • 诊断时有损害的4442例(19.9%)接受甲状旁腺切除术。
  • 进展为损害者中1348例(19.9%)后续接受甲状旁腺切除术,中位时间154天。

关键数值与推荐

  • PHPT生化诊断定义为第二次血钙升高后1个月内PTH>65 pg/mL,血钙>10.2 mg/dL或离子钙>1.3 mmol/L或>5.3 mg/dL。
  • 终末器官损害包括骨质疏松、非创伤性骨折、肾结石或3期及以上慢性肾病。

临床怎么用

  • 对PHPT患者应评估终末器官损害并考虑甲状旁腺切除术以降低相关并发症。
  • 需关注未手术患者的随访监测,及时发现损害进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Primary hyperparathyroidism (PHPT) is common and contributes to skeletal and kidney end-organ damage. Although parathyroidectomy can mitigate these complications, many patients are managed with observation, and real-world data on the population-based frequency and timing of end-organ damage under usual care are limited. OBJECTIVE: To evaluate the frequency and timing of end-organ damage associated with PHPT. DESIGN, SETTING, AND PARTICIPANTS: This cohort study included a population-based cohort identified from national electronic health record (EHR) and claims data (2010-2023) with follow-up through 2023. Participants were adults with a new biochemical diagnosis of PHPT. Data analysis was performed from August 2025 to April 2026. EXPOSURE: A new biochemical diagnosis of PHPT was defined as an elevated PTH (>65 pg/mL) within 1 month after a second elevated calcium level (serum calcium >10.2 mg/dL or ionized calcium >1.3 mmol/L or >5.3 mg/dL). MAIN OUTCOMES AND MEASURES: PHPT-associated end-organ damage (osteoporosis, atraumatic fractures, kidney stones, stage 3 or worse chronic kidney disease) at or after PHPT diagnosis using EHR or claim codes and laboratory data, in addition to the frequency and timing of parathyroidectomy. RESULTS: A total of 43 399 patients with PHPT were identified (mean [SD] age, 67.9 [12.5] years; 33 854 [78%] female and 9545 [22%] male), of whom 22 279 (51.3%) had end-organ damage at diagnosis. Among 21 120 patients without end-organ damage at diagnosis, 6762 (32.0%) progressed to end-organ damage after a median (IQR) 516 (166-1125) days. Only 4442 patients (19.9%) with end-organ damage at diagnosis were treated with parathyroidectomy. Among those who progressed to end-organ damage, 1348 (19.9%) underwent subsequent parathyroidectomy, which occurred a median (IQR) 154 (41-439) days later. CONCLUSIONS AND RELEVANCE: In this national cohort of adults with a biochemical diagnosis of PHPT, 67% had PHPT-associated end-organ damage at diagnosis or on follow-up. Despite this, parathyroidectomy was uncommon. These findings may inform strategies to optimize utilization of parathyroidectomy and mitigate PHPT-associated morbidity.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Delaney LD, Day HS, Arnow KD, et al. End-Organ Damage Associated With Primary Hyperparathyroidism. JAMA Surg. 2026. PMID: 42525408. doi:10.1001/jamasurg.2026.3051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。